RB
Rishi Bhagawat Dayal
About Rishi Bhagawat Dayal
Data last updated:
Rishi Bhagawat Dayal is a Director at Attollent Pharmaceuticals Private Limited (since 2023) and Director at Qeris Lifesciences Private Limited (since 2026). The companies operate in Trading and Business Services. The largest current company by reported revenue is Attollent Pharmaceuticals Private Limited at ₹3.18 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Attollent Pharmaceuticals Private Limited U85100DL2011PTC219321 | Director | 18 Nov 2023 | 2011 | ₹3.18 Cr (FY 2025) | Active |
| Qeris Lifesciences Private Limited U74999DL2021PTC389287 | Director | 02 Jun 2026 | 2021 | Active |
Board colleagues of Rishi Bhagawat Dayal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sachin Kumar Bahot | 10994668 | Attollent Pharmaceuticals Private Limited | Director |
| Santosh | 09588603 | Attollent Pharmaceuticals Private Limited | Director |
| Jyoti | 11275646 | Qeris Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishi Bhagawat Dayal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishi Bhagawat Dayal
Rishi Bhagawat Dayal currently holds 2 directorships: Attollent Pharmaceuticals Private Limited (Director, since 18 Nov 2023, revenue ₹3.18 Cr (FY 2025)); Qeris Lifesciences Private Limited (Director, since 02 Jun 2026).
Rishi Bhagawat Dayal was first appointed on 18 Nov 2023 as Director at Attollent Pharmaceuticals Private Limited. The most recent appointment on record is 02 Jun 2026 at Qeris Lifesciences Private Limited.
The current boards of Rishi Bhagawat Dayal's companies include Sachin Kumar Bahot (Attollent Pharmaceuticals Private Limited), Santosh (Attollent Pharmaceuticals Private Limited), Jyoti (Qeris Lifesciences Private Limited).